Behrouz Mansouri Taleghani

Dr. Behrouz Mansouri Taleghani


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2018 in Transfusion Medicine and Hemotherapy
Verified
Journal Article
Open access
PDF file
JRJohanna Reckhaus
Johanna Reckhaus
MJMarkus Jutzi
Markus Jutzi
SFStefano Fontana
Stefano Fontana
VBVera Ulrike Bacher
Vera Ulrike Bacher
MVMarco Vogt
Marco Vogt
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani
Background: Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being higher in pooled buffy coat PC (BC-PC) than in apheresis units (AP-PC). Data about PC-induced alloimmunization against non-D Rhesus (Rh) antigens are limited. Methods: For all newly detected RhD and non-D alloantibodies between August 2015 and September /2017 we prospectively evaluated if they were triggered through PC by analyzing for incompatible RBC and/or PC transfusions. Results: We found 5,799 positive results in 89,190 antibody screening tests. We identified 13 newly detectable Rh antibodies through incompatible PCs in 11 patients: 6× anti-D, 4× anti-E, 2× anti-c, 1× anti-f. They received a total of 156 PC (83 BC-PC; 73 AP-PC): 5 patients received incompatible BC-PC only, 1 patient received incompatible AP-PC only, 5 patients received incompatible BC-PC and AP-PC. Quality control showed a mean (range) of 0.304 (0.152-1.662) and 0.014 (0.003-0.080) × 109 RBC/l for BC-PC and AP-PC, respectively. Ten of the 11 patients received RBC transfusions, all of them being antigen-negative for the alloantibodies identified. Conclusions: PC transfusions may not only induce RhD alloimmunization, but also immunization against further Rh antigens such as c, E, and f. The risk seems higher for BC-PC than for AP-PC. The results may have impact on future recommendations of PC transfusion with respect to Rh compatibility and upper limits of RBC contamination.

1 September 2001 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani
RGRalf Grossmann
Ralf Grossmann
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

27 October 2006 in Transfusion
Verified
Journal Article
Closed access
PDF file
FLFreidrich Lersch
Freidrich Lersch
SFStefano Fontana
Stefano Fontana
FNFelix Nohl
Felix Nohl
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani

1 January 1997
Verified
Journal Article
Closed access
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani
FMF Manke
F Manke
RLR Langer
R Langer
HHH A Henrich
H A Henrich
RGR Grossmann
R Grossmann
DWD Wiebecke
D Wiebecke

8 November 2019 in Transfusion Medicine and Hemotherapy
Verified
Journal Article
Open access
PDF file
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani
ABAndreas Buser
Andreas Buser
Our last issue of Transfusion Medicine and Hemotherapy with focus on “therapeutic apheresis” has been published 7 years ago, and the editorial started with: “Therapeutic (hem)apheresis (TA) using automated blood processing equipment is a highly developed technique to selectively deplete, exchange, replace, or at least manipulate particular cellular or soluble blood constituents in a broad panel of different diseases. Starting almost 100 years ago by Abel and co-workers in 1914 [1], it still continues to expand as the pathomechanisms of new and old disease entities are elucidated, confirming ‘old’ indications or revealing new rationales for the application of TA” [1]. The phenomenon of an incremental pace of continued rise of knowledge is unquestionably also true for this field of medicine. While, for example, 95 pages were needed for the “2010 ASFA guidelines” [2], the current version of the guidelines had to be extended to 184 pages [3]. This reflects the growing quality and quantity of evidence supporting the use of TA in various diseases and patients, in order to relieve symptoms (symptomatic therapy) or even save lives. The present issue of Transfusion Medicine and Hemotherapy again includes contributions of experts for TA evidenced by their own experience and/or the available literature.

1 March 2001 in AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
Verified
Journal Article
Closed access
PDF file
BTBehrouz Mansouri Taleghani
Behrouz Mansouri Taleghani
RLR. Langer
R. Langer
RGR. Grossmann
R. Grossmann
AOA. Opitz
A. Opitz
UHU. Halbsguth
U. Halbsguth
DWD. Wiebecke
D. Wiebecke
Leukozytendepletion - Vollblut - Erythrozytenkonzentrat - Biochemische Lagerungsqualität - Rheologische Lagerungsqualität Leucocyte depletion - Whole blood - Red cell concentrate - Biochemical storage lesion - Rheological storage lesion